Skip to main content
Signal8
Naughton Gail K profile photo

Gail K. Naughton

CIK: 0001297506

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (50.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TherapeuticsMD, Inc. logo
TXMD

TherapeuticsMD, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • TherapeuticsMD, Inc. logo
    TXMD

    TherapeuticsMD, Inc.

    Nov 3, 2025
    Award(A)

    Restricted Stock Units

    Direct
    8.5K shares-
  • TherapeuticsMD, Inc. logo
    TXMD

    TherapeuticsMD, Inc.

    Feb 18, 2025
    Exercise(M)
    Direct
    8.5K shares-

1-2 of 2

About Naughton Gail K

Naughton Gail K (SEC CIK 0001297506) files insider reports with the SEC as Director of TherapeuticsMD, Inc. (TXMD).

Signal8 holds 2 ownership filings by Naughton Gail K, all Form 4s, filed between Feb 20, 2025 and Nov 5, 2025. Those filings report 2 transactions, from Feb 18, 2025 to Nov 3, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Naughton Gail K's filings is in BOCA RATON, FL.

Recent filings by Naughton Gail K

  • Nov 3, 2025: Grant or award of TXMD derivative securities (Form 4, code A).
  • Feb 18, 2025: Option exercise of TXMD shares (Form 4, code M).

Other insiders filing for TherapeuticsMD, Inc. (TXMD)

How to read Form 4 transaction codes